Skip to main content
Q BioMed Inc. (QBIO)
OTCMKTS: QBIO · Delayed Price · USD
0.0001
-0.0005 (-83.33%)
Jun 17, 2024, 12:20 PM EDT - Market closed

Q BioMed Revenue

Q BioMed had revenue of $15.04K in the twelve months ending August 31, 2023, down -96.01% year-over-year. In the fiscal year ending November 30, 2022, Q BioMed had annual revenue of $284.35K with 45.38% growth.

Revenue (ttm)
$15.04K
Revenue Growth
-96.01%
P/S Ratio
0.97
Revenue / Employee
$5,012
Employees
3
Market Cap
14.51K USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Nov 30, 2022284.35K88.76K45.38%
Nov 30, 2021195.60K165.60K551.99%
Nov 30, 202030.00K--
Nov 30, 20190--
Nov 30, 20180--
Nov 30, 20170--
Nov 30, 20160--
Nov 30, 20150--
Nov 30, 20140--
Nov 30, 20130--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 379.49B
Johnson & Johnson 81.80B
Merck & Co. 61.40B
AbbVie 54.40B
Novartis AG 49.92B
AstraZeneca 47.61B
Thermo Fisher 42.49B
Abbott Laboratories 40.33B
Revenue Rankings

QBIO News

More News